Warning: Declaration of Suffusion_MM_Walker::start_el($output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $item, $depth = 0, $args = Array, $id = 0) in /home/hygiol5/public_html/wp-content/themes/suffusion/library/suffusion-walkers.php on line 39
Jan 132014
 

The Hygiology Post ®  is presenting information about a company that seems to have much potential to help many people. The years 2012, 2013, and 2014 do appear to likely be pivotal years in determining how helpful the patented technologies may actually be for people. Senesco Technologies has continued to update information on its web site. As a matter of disclosure : The author continues to be a current shareholder in the company.

An article recently posted on the Senesco Technologies web site (https://www.senesco.com/newsitem.php?id=294; obtained on 1-11-14) began the following way:

1/9/2014

Senesco to Present at Biotech Showcase™ 2014

Bridgewater, NJ – (January 9, 2014) – Senesco Technologies, Inc. (‘Senesco’ or the ‘Company’) (OTCQB: SNTI), today announced that Leslie J. Browne, Ph.D., President and CEO of Senesco, will present a corporate update on Monday, January 13, at 10.30 a.m. (Pacific Time) at the Biotech Showcase 2014 Conference being held in San Francisco, CA.

Details of Senesco’s presentation are as follows:

Event: Biotech Showcase™ 2014 Conference

Date: Monday, January 13, 2014

Time: 10.30 a.m. (Pacific)

Location: Powell Room: Parc 55 Wyndham San Francisco Union Square Hotel

About Senesco Technologies, Inc.

Senesco Technologies is a clinical-stage biotech company specializing in cancer therapeutics. Its proprietary gene regulation technology has demonstrated the ability to kill cancer cells and protect healthy cells from premature death in disease models. The Company is currently in a Phase 1b/2a trial with a product candidate that is designed to treat B-cell cancers, which include multiple myeloma, chronic lymphocytic leukemia, and non-Hodgkin’s B-cell lymphomas. Trial sites include Mayo Clinic and the Fred Hutchinson Cancer Research Center in Seattle. The technology was developed over the last 15 years through the discovery that the genetic pathway for cell growth control is common to both plants and humans. For more information, please visit Senesco.com or connect with us on Facebook, Twitter, LinkedIn and Google+.”

 

The Hygiology Post ® welcomes feedback from readers as to whether the articles (individually and/or collectively) help fulfill its vision and mission.

 

Louis DeCola, Jr.  © 2014                                    The Hygiology Post ®